Regulation of neurosteroid biosynthesis by neurotransmitters and neuropeptides

Frontiers in Endocrinology

Volumn 3, Issue JAN, 2012, Pages

  Rego, Jean Luc Do ^a,b,c   Seong, Jae Young ^d   Burel, Delphine ^a,b,c   Leprince, Jerôme ^a,b,c   Vaudry, David ^a,b,c   Luu The, Van ^e   Tonon, Marie Christine ^a,b,c   Tsutsui, Kazuyoshi ^f   Pelletier, Georges ^e   Vaudry, Hubert ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE ROUEN   (France)

^c International Associated Laboratory Samuel de Champlain   (France)

^d Korea University College of Medicine   (South Korea)

^e LAVAL UNIVERSITY   (Canada)

^f WASEDA UNIVERSITY   (Japan)

Author keywords

Endozepines; GABA; Glutamate; Melatonin; Neuropeptide Y; Neurosteroids; Prolactin; Vasopressin

Indexed keywords

EID: 84874434434     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2012.00004     Document Type: Article

References (282)

1. Alescio-Lautier, B., and Soumireu-Mourat, B. (1998). Role of vasopressin in learning and memory in the hippocampus. Prog. Brain Res. 119, 501-521.
2. Alho, H., Bovolin, P., Jenkins, D., Guidotti, A., and Costa, E. (1989). Cellular and subcellular localization of an octadecaneuropeptide derived from diazepam binding inhibitor: immunohistochemical studies in the rat brain. J. Chem. Neuroanat. 2, 301-318.
3. Alho, H., Fremeau, R. T. Jr., Tiedge, H., Wilcox, J., Bovolin, P., Broslus, J., Roberts, J. L., and Costa, E. (1988). Diazepam binding inhibitor gene expression: location in brain and peripheral tissues of rat. Proc. Natl. Acad. Sci. U.S.A. 85, 7018-7022.
4. Alho, H., Kolmer, M., Harjuntausta, T., and Helen, P. (1995). Increased expression of diazepam binding inhibitor in human brain tumors. Cell Growth Differ. 6, 309-314.
5. Allen, Y. S., Adrian, T. E., Allen, J. M., Tatemoto, K., Crow, T. J., Bloom, S. R., and Polak, J. M. (1983). Neuropeptide Y distribution in the rat brain. Science 221, 877-879.
6. Aller, M. I., Janusonis, S., Fite, K. V., and Fernández-López, A. (1997). Distribution of the GABAA receptor complex β2/3 subunits in the brain of the frog Rana pipiens. Neurosci. Lett. 225, 65-68.
7. Amikishieva, A. V., Ilnitskaya, S. I., Nikolin, V. P., and Popova, N. A. (2011). Effect of vasopressin V1B receptor antagonist, SSR149415, on anxietylike behavior and Lewis lung carcinoma metastasis in mice. Exp. Oncol. 33, 126-129.
8. Anholt, R. R., Murphy, K. M., Mack, G. E., and Snyder, S. H. (1984). Peripheraltype benzodiazepine receptors in the central nervous system: localization to olfactory nerves. J. Neurosci. 4, 593-603.
9. Aste, N., Viglietti-Panzica, C., Fasolo, A., Andreone, C., Vaudry, H., Pelletier, G., and Panzica, G. C. (1991). Localization of neuropeptide Y-immunoreactive cells and fibres in the brain of the Japanese quail. Cell Tissue Res. 265, 219-230.
10. Bäckberg, M., Ultenius, C., Fritschy, J. M., and Meister, B. (2004). Cellular localization of GABA receptor α subunit immunoreactivity in the rat hypothalamus: relationship with neurons containing orexigenic or anorexigenic peptides. J. Neuroendocrinol. 16, 589-604.
11. Balthazart,J. (1997). Steroid control and sexual differentiation of brain aromatase. J. Steroid Biochem. Mol. Biol. 61, 323-339.
12. Balthazart, J., Baillien, M., and Ball, G. F. (2001a). Rapid and reversible inhibition of brain aromatase activity. J. Neuroendocrinol. 13, 63-73.
13. Balthazart, J., Baillien, M., and Ball, G. F. (2001b). Phosphorylation processes mediate rapid changes of brain aromatase activity. J. Steroid Biochem. Mol. Biol. 79, 261-277.
14. Balthazart, J., Baillien, M., Charlier, T. D., Cornil, C. A., and Ball, G. F. (2001c). Multiple mechanisms control brain aromatase activity at the genomic and nongenomic level. J. Steroid Biochem. Mol. Biol. 86, 367-379.
15. Balthazart, J., Baillien, M., Charlier, T. D., and Ball, G. F. (2003). Calciumdependent phosphorylation processes control brain aromatase in quail. Eur. J. Neurosci. 17, 1591-1606.
16. Barbaccia, M. L., Roscetti, G., Trabucchi, M., Purdy, R. H., Mostallino, M. C., Perra, C., Concas, A., and Biggio, G. (1996). Isoniazidinduced inhibition of GABAergic transmission enhances neurosteroid content in the rat brain. Neuropharmacology 35, 1299-1305.
17. Baulieu, E. E. (1997). Neurosteroids: of the nervous system by the nervous system, for the nervous system. Recent Prog. Horm. Res. 52, 1-32.
18. Baulieu, E. E. (1998). Neurosteroids: a novel function of the brain. Psychoneuroendocrinology 23, 963-987.
19. Baulieu, E. E., Robel, P., and Schumacher, M. (1999). "Neurosteroids: a new regulatory function in the nervous system," eds E. E. Baulieu, P. Robel, and M. Schumacher (Totowa, NJ: Humana Press), 1-26.
20. Beaujean, D., Do Rego, J. L., Galas, L., Mensah-Nyagan, A. G., Fredriksson, R., Larhammar, D., Fournier, A., Luu-The, V., Pelletier, G., and Vaudry, H. (2002). Neuropeptide Y inhibits the biosynthesis of sulfated neurosteroids in the hypothalamus through activation of Y1 receptors. Endocrinology 143, 1950-1963.
21. Beaujean,D.,Mensah-Nyagan,A. G.,Do Rego, J. L., Luu-The, V., Pelletier, G., and Vaudry, H. (1999). Immunocytochemical localization and biological activity of hydroxysteroid sulfotransferase in the frog brain. J. Neurochem. 72, 848-857.
22. Beck, B. (2006). Neuropeptide Y in normal eating and in genetic and dietaryinduced obesity. Philos. Trans. R. Soc. Lond. B Biol. Sci. 361, 1159-1185.
23. Belelli, D., Bolger, M. B., and Gee, K. W. (1989). Anticonvulsant profile of the progesterone metabolite 3α-hydroxy 5α-pregnan-20-one. Eur. J. Pharmacol. 166, 325-329.
24. Belelli, D., Herd, M. B., Mitchell, E. A., Peden, D. R., Vardy, A. W., Gentet, L., and Lambert, J. J. (2006). Neuroactive steroids and inhibitory neurotransmission: mechanisms of action and physiological relevance. Neuroscience 138, 821-829.
25. Belelli, D., and Lambert, J. J. (2005). Neurosteroids: endogenous regulators of the GABAA receptor. Nat. Rev. Neurosci. 6, 565-575.
26. Benavides, J., Quarteronet, D., Imbault, F., Malgouris, C., Uzan, A., Renault, C., Dubroeucq, M. C., Gueremy, C., and Le Fur, G. (1983a). Labelling of "peripheraltype" benzodiazepine binding sites in the rat brain by using [3H]PK 11195, an isoquinoline carboxamide derivative: kinetic studies and autoradiographic localization. J. Neurochem. 41, 1744-1750.
27. Benavides, J., Malgouris, C., Imbault, F., Begassat, F., Uzan, A., Renault, C., Dubroeucq, M. C., Gueremy, C., and Le Fur, G. (1983b). "Peripheral type" benzodiazepine binding sites in rat adrenals: binding studies with [3H]PK 11195 and autoradiographic localization. Arch. Int. Pharmacodyn. Ther. 266, 38-49.
28. Bergeron, R., de Montigny, C., and Debonnel,G. (1996). Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors. J. Neurosci. 16, 1193-1202.
29. Besman, M. J., Yanagibashi, K., Lee, T. D., Kawamura, M., Hall, P. F., and Shively, J. E. (1989). Identification of des-(Gly-Ile)-endozepine as an effector of corticotropindependent adrenal steroidogenesis: stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor. Proc. Natl. Acad. Sci. U.S.A. 86, 4897-4901.
30. Bons, N., Mestre, N., Petter, A., Danger, J. M., Pelletier, G., and Vaudry, H. (1990). Localization and characterization of neuropeptide Y in the brain of Microcebus murinus (Primate, Lemurian). J. Comp. Neurol. 298, 343-361.
31. Bowlby, M. R. (1993). Pregnenolone sulfate potentiation of N-methyl-D-aspartate receptor channels in hippocampal neurons. Mol. Pharmacol. 43, 813-819.
32. Braestrup, C., and Squires, R. F. (1977). Specific benzodiazepine receptors in rat brain characterized by highaffinity (3H)diazepam binding. Proc. Natl. Acad. Sci. U.S.A. 74, 3805-3809.
33. Bullock, A. E., Clark, A. L., Grady, S. R., Robinson, S. F., Slobe, B. S., Marks, M. J., and Collins, A. C. (1997). Neurosteroids modulate nicotinic receptor function in mouse striatal and thalamic synaptosomes. J. Neurochem. 68, 2412-2423.
34. Bürgi, B., Lichtensteiger, W., Lauber, M. E., and Schlumpf, M. (1999). Ontogeny of diazepam binding inhibitor/acyl-CoA binding protein mRNA and peripheral benzodiazepine receptor mRNA expression in the rat. J. Neuroendocrinol. 11, 85-100.
35. Chadwick, C. S. (1941). Identity of prolactin with water drive factor in Triturus viridescens. Proc. Soc. Exp. Biol. Med. 45, 335-337.
36. Charalampopoulos, I., Tsatsanis, C., Dermitzaki, E., Alexaki, V. I., Castanas, E., Margioris, A. N., and Gravanis, A. (2004). Dehydroepiandrosterone and allopregnanolone protect sympathoadrenal medulla cells against apoptosis via antiapoptotic Bcl-2 proteins. Proc. Natl. Acad. Sci. U.S.A. 101, 8209-8214.
37. Chartrel, N., Conlon, J. M., Danger, J. M., Fournier, A., Tonon, M. C., and Vaudry, H. (1991). Characterization of melanotropinreleaseinhibiting factor (melanostatin) from frog brain: homology with human neuropeptide Y. Proc. Natl. Acad. Sci. U.S.A. 88, 3862-3866.
38. Compagnone, N. A., and Mellon, S. H. (1998). Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development. Proc. Natl. Acad. Sci. U.S.A. 95, 4678-4683.
39. Compagnone, N. A., and Mellon, S. H. (2000). Neurosteroids: biosynthesis and function of these novel neuromodulators. Front. Neuroendocrinol. 21, 1-56.
40. Cornil, C., Foidart, A., Minet, A., and Balthazart, J. (2000). Immunocytochemical localization of ionotropic glutamate receptors subunits in the adult quail forebrain. J. Comp. Neurol. 428, 577-608.
41. Cornil, C. A. (2009). Rapid regulation of brain oestrogen synthesis: the behavioural roles of oestrogens and their fates. J. Neuroendocrinol. 21, 217-226.
42. Corpéchot, C., Robel, P., Axelson, M., Sjövall, J., and Baulieu, E. E. (1981). Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc. Natl. Acad. Sci. U.S.A. 78, 4704-4707.
43. Corpéchot, C., Synguelakis, M., Talha, S., Axelson, M., Sjövall, J., Vihko, R., Baulieu, E. E., and Robel, P. (1983). Pregnenolone and its sulfate ester in the rat brain. Brain Res. 270, 119-125.
44. Costa, E. T., Soto, E. E., Cardoso, R. A., Olivera, D. S., and Valenzuela, C. F. (2000). Acute effects of ethanol on kainate receptors in cultured hippocampal neurons. Alcohol. Clin. Exp. Res. 24, 220-225.
45. Croiset, G., Nijsen, M. J. M. A., and Kamphuis, P. J. G. H. (2000). Role of corticotrophinreleasing factor, vasopressin and autonomic nervous system in learning and memory. Eur. J. Pharmacol. 405, 225-234.
46. Damianisch,K.,Rupprecht,R.,and Lancel, M. (2001). The influence of subchronic administration of the neurosteroid allopregnanolone on sleep in the rat. Neuropsychopharmacology 25, 576-584.
47. Danger, J. M., Breton, B., Vallarino, M., Fournier, A., Pelletier, G., and Vaudry, H. (1991). Neuropeptide-Y in the trout brain and pituitary: localization, characterization, and action on gonadotropin release. Endocrinology 128, 2360-2368.
48. Danger, J. M., Guy, J., Benyamina, J., Jégou, S., Leboulenger, F., Coté, J., Tonon, M. C., Pelletier, G., and Vaudry, H. (1985). Localization and identification of neuropeptide Y (NPY)-like immunoreactivity in the frog brain. Peptides 6, 1225-1236.
49. Danger, J. M., Tonon, M. C., Jenks, B. G., Saint-Pierre, S., Martel, J. C., Fasolo, A., Breton, B., Quirion, R., Pelletier, G., and Vaudry, H. (1990). Neuropeptide Y: localization in the central nervous system and neuroendocrine functions. Fundam. Clin. Pharmacol. 4, 307-340.
50. Darnaudery, M., Pallarès, M., Piazza, P. V., Le Moal, M., and Mayo, W. (2002). The neurosteroid pregnenolone sulfate infused into the medial septum nucleus increases hippocampal acetylcholine and spatial memory in rats. Brain Res. 95, 237-242.
51. De Montis,G. M.,Olianas,M. C.,Mulas, G., Lloyd, K. G., and Tagliamonte, A. (1981). GABA receptors distribution in rat substantia nigra. Neurosci. Lett. 23, 257-261.
52. De Quidt, M. E., and Emson, P. C. (1986). Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system II. Immunohistochemical analysis. Neuroscience 18, 545-618.
53. De Wied, D., Diamant, M., and Fodor, M. (1993). Central nervous system effects of the neurohypophyseal hormones and related peptides. Front. Neuroendocrinol. 14, 251-302.
54. Dewan, A. K., Ramey, M. L., and Tricas, T. C. (2011). Arginine vasotocin neuronal phenotypes, telencephalic fiber varicosities,and social behavior in butterflyfishes (Chaetodontidae): potential similarities to birds and mammals. Horm. Behav. 59, 56-66
55. Diotel, N., Do Rego, J. L., Anglade, I., Vaillant, C., Pellegrini, E., Gueguen, M. M., Mironov, S., Vaudry, H., and Kah, O. (2011). Activity and expression of steroidogenic enzymes in the brain of adult zebrafish. Eur. J. Neurosci. 34, 45-56.
56. Diotel, N., Le Page, Y., Mouriec, K., Tong, S. K., Pellegrini, E., Vaillant, C., Anglade, I., Brion, F., Pakdel, F., Chung, B. C., and Kah, O. (2010). Aromatase in the brain of teleost fish: expression, regulation and putative functions. Front. Neuroendocrinol. 31, 172-192.
57. Djebaili, M., Hoffman, S. W., and Stein, D. G. (2004). Allopregnanolone andprogesterone decrease cell death and cognitive deficits after a contusion of the rat prefrontal cortex. Neuroscience 123, 349-359.
58. Do Rego, J. C., Orta, M. H., Leprince, J., Tonon, M. C., Vaudry, H., and Costentin, J. (2007). Pharmacological characterization of the receptor mediating the anorexigenic action of the octadecaneuropeptide: evidence for an endozepinergic tone regulating food intake. Neuropsychopharmacology 32, 1641-1648.
59. Do Rego, J. L., Acharjee, S., Seong, J. Y., Galas, L., Alexandre, D., Bizet, P., Burlet, A., Kwon, H. B., Luu-The, V., Pelletier, G., and Vaudry, H. (2006). Vasotocin and mesotocin stimulate the biosynthesis of neurosteroids in the frog brain. J. Neurosci. 26, 6749-6760.
60. Do Rego, J. L., Mensah-Nyagan, A. G., Beaujean, D., Leprince, J., Tonon, M. C., Luu-The, V., Pelletier, G., and Vaudry, H. (2001). The octadecaneuropeptide ODN stimulates neurosteroid biosynthesis through activation of centraltype benzodiazepine receptors. J. Neurochem. 76, 128-138.
61. Do Rego, J. L., Mensah-Nyagan, A. G., Beaujean, D., Vaudry, D., Sieghart, W., Luu-The, V., Pelletier, G., and Vaudry, H. (2000). GABA, acting through GABAA receptors, inhibits biosynthesis of neurosteroids in the frog hypothalamus. Proc. Natl. Acad. Sci. U.S.A. 97, 13925-13930.
62. Do Rego, J. L., Mensah-Nyagan, A. G., Feuilloley, M., Ferrara, P., Pelletier, G., and Vaudry, H. (1998). The endozepine triakontatetraneuropeptide diazepambinding inhibitor [17-50] stimulates neurosteroid biosynthesis in the frog hypothalamus. Neuroscience 83, 555-570.
63. Do Rego, J. L., Seong, J. Y., Burel, D., Leprince, J., Luu-The, V., Tsutsui, K., Tonon, M. C., Pelletier, G., and Vaudry, H. (2009). Neurosteroid biosynthesis: enzymatic pathways and neuroendocrine regulation by neurotransmitters and neuropeptides. Front. Neuroendocrinol. 30, 259-301.
64. Do Rego, J. L., Tremblay, Y., Luu-The, V., Repetto, E., Castel, H., Vallarino, M., Bélanger, A., Pelletier, G., and Vaudry, H. (2007a). Immunohistochemical localization and biological activity of the steroidogenic enzyme cytochrome P450 17α-hydroxylase/C17,20-lyase (P450C17) in the frog brain and pituitary. J. Neurochem. 100, 251-268.
65. Do Rego, J. L., Leprince, J., Luu-The, V., Pelletier, G., Tonon, M. C., and Vaudry, H. (2007b). Structureactivity relationships of a series of analogs of the endozepine octadecaneuropeptide (ODN11-18)onneurosteroid biosynthesis by hypothalamic explants. J. Med. Chem. 50, 3070-3076.
66. Dubrovsky, B. O. (2005). Steroids, neuroactive steroids and neurosteroids in psychopathology. Prog. Neuropsychopharmacol. Biol. Psychiatry 29, 169-192.
67. Dumont, Y., and Quirion, R. (2006). "Neuropeptide Y," in Handbook of Biologically Active Peptides, ed. A. J. Kastin (New York: Academic Press), 683-688.
68. Duparc, C., Lefebvre, H., Tonon, M. C., Vaudry, H., and Kuhn, J. M. (2003). Characterization of endozepines in the human testicular tissue: effect of triakontatetraneuropeptide on testosterone secretion. J. Clin. Endocrinol. Metab. 88, 5521-5528.
69. Engel, S. R., and Grant, K. A. (2001). Neurosteroids and behavior. Int. Rev. Neurobiol. 46, 321-348.
70. Engelmann, M. (2008). Vasopressin in the septum: not important versus causally involved in learning and memory -two faces of the same coin? Prog. Brain Res. 170, 389-395.
71. Engelmann, M., Wotjak, C. T., Ebner, K., and Landgraf, R. (2000). Behavioral impact of intraseptally released vasopressin and oxytocin in rats. Exp. Physiol. 85, 125S-130S.
72. Everts, H. G. J., and Koolhaas, J. M. (1999). Differential modulation of lateral septal vasopressin receptor blockade in spatial learning, social recognition, and anxietyrelated behaviors in rats. Behav. Brain Res. 99, 7-16.
73. Fahey, J. M., Miller, L. G., and Isaacson, R. L. (1995a). Neurosteroid modulation of locomotor activity in mice. Neurosci. Res. Commun. 17, 159-167.
74. Fahey, J. M., Lindquist, D. G., Pritchard, G. A., and Miller, L. G. (1995b). Pregnenolone sulfate potentiation of NMDA-mediated increases in intracellular calcium in cultured chick cortical neurons. Brain Res. 669, 183-188.
75. Ferrero, P., Guidotti, A., and Conti-Tronconi, B. (1984). A brain octadecaneuropeptide generated by tryptic digestion of DBI (diazepam binding inhibitor) functions as a proconflict ligand of benzodiazepine recognition sites. Neuropharmacology 23, 1359-1362.
76. Ferris, C. F., Melloni, R. H. Jr., Koppel, G., Perry, K. W., Fuller, R. W., and Delville, Y. (1997). Vasopressin/serotonin interactions in the anterior hypothalamus control aggressive behavior in golden hamsters. J. Neurosci. 17, 4331-4340.
77. Flood, J. F., Morley, J. E., and Roberts, E. (1992). Memoryenhancing effects in male mice of pregnenolone and steroids metabolically derived from it. Proc. Natl. Acad. Sci. U.S.A. 89, 1567-1571.
78. Flood, J. F., Smith, G. E., and Roberts, E. (1988). Dehydroepiandrosterone and its sulfate enhance memory retention in mice. Brain Res. 447, 269-278.
79. Frank, C., and Sagratella, S. (2000). Neuroprotective effects of allopregnenolone on hippocampal irreversible neurotoxicity in vitro. Prog. Neuropsychopharmacol. Biol. Psychiatry 24, 1117-1126.
80. Franzoni, M. F., and Morino, P. (1989). The distribution of GABA-likeimmunoreactive neurons in the brain of the newt, Tritucus cristatus carnifex, and the green frog Rana esculenta. Cell Tissue Res. 255, 155-166.
81. Frye, C. A. (2001). The role of neurosteroids and nongenomic effects of progestins and androgens in mediating sexual receptivity of rodents. Brain Res. Rev. 37, 201-222.
82. Garcia de Mateos-Verchere, J., Leprince, J., Tonon, M. C., Vaudry, H., and Costentin, J. (1999). Reduction of pentylenetetrazolinduced convulsions by the octadecaneuropeptide ODN. Peptides 20, 1431-1436.
83. Garcia de Mateos-Verchere, J., Leprince, J., Tonon, M. C., Vaudry, H., and Costentin, J. (2001). The octadecaneuropeptide [diazepambinding inhibitor (33-50)] exerts potent anorexigenic effects in rodents. Eur. J. Pharmacol. 414, 225-231.
84. Garnier, M., Boujrad, N., Ogwuegbu, S. O., Hudson, J. R. Jr., and Papadopoulos, V. (1994). The polypeptide diazepambinding inhibitor and a higher affinity mitochondrial peripheraltype benzodiazepine receptor sustain constitutive steroidogenesis in the R2C Leydig tumor cell line. J. Biol. Chem. 269, 22105-22112.
85. Garnier, M., Boujrad, N., Oke, B. O., Brown, A. S., Riond, J., Ferrara, P., Shoyab, M., Suarez-Quian, C. A., and Papadopoulos, V. (1993). Diazepam binding inhibitor is a paracrine/autocrine regulator of Leydig cell proliferation and steroidogenesis: action via peripheraltype benzodiazepine receptor and independent mechanisms. Endocrinology 132, 444-458.
86. Geese, W. J., and Raftogianis, R. B. (2001). Biochemical characterization and tissue distribution of human SULT2B1. Biochem. Biophys. Res. Commun. 288, 280-289.
87. Gehlert, D. R., Yamamura, H. I., and Wamsley, J. K. (1985). Autoradiographic localization of "peripheraltype" benzodiazepine binding sites in the rat brain, heart and kidney. Naunyn Schmiedebergs Arch. Pharmacol. 328, 454-460.
88. Gibbs, J. L., Flores, C. M., and Hargreaves, K. M. (2006). Attenuation of capsaicinevoked mechanical allodynia by peripheral neuropeptide Y Y1 receptors. Pain 124, 167-174.
89. Goodson, J. L., Kabelik, D., and Schrock, S. E. (2009). Dynamic neuromodulation of aggression by vasotocin: influence of social context and social phenotype in territorial songbirds. Biol. Lett. 5, 554-556.
90. Goodson, J. L., Lindberg, L., and Johnson, P. (2004). Effects of central vasotocin and mesotocin manipulations on social behavior in male and female zebra finches. Horm. Behav. 45, 136-143.
91. Grazzini, E., Guillon, G., Mouillac, B., and Zingg, H. H. (1998). Inhibition of oxytocin receptor function by direct binding of progesterone. Nature 392, 509-512.
92. Guarneri, P., Guarneri, R., Cascio, C., Piccoli, F., and Papadopoulos, V. (1995). γ-aminobutyric acid type A/benzodiazepine receptors regulate rat retina neurosteroidogenesis. Brain Res. 683, 65-72.
93. Guidotti,A. (1991). Role of DBI in brain and its posttranslational processing products in normal and abnormal behavior. Neuropharmacology 30, 1425-1433.
94. Guidotti, A., Forchetti, C. M., Corda, M. G., Kondel, D., Bennett, C. D., and Costa, E. (1983). Isolation, characterization and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. Proc. Natl. Acad. Sci. U.S.A. 80, 3531-3535.
95. Gursoy, E., Cardounel, A., and Kalimi, A. (2001). Pregnenolone protects mouse hippocampal (HT-22) cells against glutamate and amyloid beta protein toxicity. Neurochem. Res. 26, 15-21.
96. Harada, N. (1988). Novel properties of human placental aromatase as cytochrome P-450: purification and characterization of a unique form of aromatase. J. Biochem. 103, 106-113.
97. Haraguchi, S., Koyama, T., Do Rego, J. L., and Tsutsui, K. (2009). Seasonal changes in the synthesis of 7α-hydroxypregnenolone stimulatinglocomotoractivityin newts. Ann.N.Y.Acad.Sci. 1163, 410-413
98. Haraguchi, S., Koyama, T., Hasunuma, I., Vaudry, H., and Tsutsui, K. (2010). Prolactin increases the synthesis of 7α-hydroxypregnenolone, a key factor for induction of locomotor activity, in breeding male newts. Endocrinology 151, 2211-2222.
99. Hau, M., and Gwinner, E. (1994). Melatonin facilitates synchronization of sparrow circadian rhythms to light. J. Comp. Physiol. A 175, 343-347.
100. He, J., Hoffman, S. W., and Stein, D. G. (2004). Allopregnanolone, a progesterone metabolite, enhances behavioral recovery and decreases neuronal loss after traumatic brain injury. Restor. Neurol. Neurosci. 22, 19-31.
101. Heinrichs, M., and Domes, G. (2008). Neuropeptides and social behavious: effect of oxytocin and vasopressin in humans. Prog. Brain Res. 170, 337-350.
102. Hendry, S. H. (1993). "Organization of neuropeptide Y neurons in the mammalian central nervous system," in The Biology of Neuropeptide Y and Related Peptides,edsW.F. Colmers and C. Wahlested (Totowa, NJ: Humana Press), 65-156.
103. Hodge, C. W., Raber, J., McMahon, T., Walter, H., Sanchez-Perez, A. M., Olive, M. F., Mehmert, K., Morrow, A. L., and Messing, R. O. (2002). Decreased anxietylike behavior, reduced stress hormones, and neurosteroid supersensitivity in mice lacking protein kinase Cepsilon. J. Clin. Invest. 110, 1003-1010
104. Hollis, D. M., and Boyd, S. K. (2005). Distribution of GABA-like immunoreactive cell bodies in the brains of two amphibians, Rana catesbeiana and Xenopus laevis. Brain Behav. Evol. 65, 127-142.
105. Hollis, D. M., Goetz, F. W., Roberts, S. B., and Boyd, S. K. (2004). Acute neurosteroid modulation and subunit isolation of the gammaaminobutyric acidA receptor in the bullfrog, Rana catesbeina. J. Mol. Endocrinol. 32, 921-934.
106. Horishita, T., Minami, K., Uezono, Y., Shiraishi, M., Ogata, J., Okamoto, T., Terada, T., and Sata, T. (2005). The effects of the neurosteroids: pregnenolone, progesterone and dehydroepiandrosterone on muscarinic receptorinduced responses in Xenopus oocytes expressing M1 and M3 receptors. Naunyn Schmiedebergs Arch. Pharmacol. 371, 221-228
107. Hu, Y., Cardounel, A., Gursoy, E., Anderson, P., and Kalimi, M. (2000). Antistress effects of dehydroepiandrosterone: protection of rats against repeated immobilization stressinduced weight loss, glucocorticoid receptor production, and lipid peroxidation. Biochem. Pharmacol. 59, 753-762.
108. Inai, Y., Nagai, K., Ukena, K., Oishi, T., and Tsutsui, K. (2003). Seasonal changes in neurosteroid concentrations in the amphibian brain and environmental factors regulating their changes. Brain Res. 959, 214-225.
109. 2+ in cultured rat hippocampal neurons. Neurosci. Lett. 141, 30-34
110. Iwata, M., Muneoka, K. T., Shirayama, Y., Yamamoto, A., and Kawahara, R. (2005). A study of a dendritic marker, microtubuleassociated protein 2 (MAP-2), in rats neonatally treated neurosteroids, pregnenolone and dehydroepiandrosterone (DHEA). Neurosci. Lett. 386, 145-149.
111. Iwata, T., Toyoda, F., Yamamoto, K., and Kikuyama, S. (2000). Hormonal control of urodele reproductive behavior. Comp. Biochem. Physiol. B. Biochem. Mol. Biol. 126, 221-229.
112. Jiang, P.,Yang, C. X.,Wang,Y. T., and Xu, T. L. (2006). Mechanisms of modulation of pregnanolone on glycinergic response in cultured spinal dorsal horn neurons of rat. Neuroscience 141, 2041-2050.
113. Jo, D. H., Sánchez de la Peña, S., Halberg, F., Ungar, F., Baulieu, E. E., and Robel, P. (1990). Circadianinfradian rhythmic variation of brain neurosteroids in the female rat. Prog. Clin. Biol. Res. 341B, 125-134
114. Jones, K. (1994). Androgenic enhancement of motor neuron regeneration. Ann. N. Y. Acad. Sci. 743, 141-164.
115. Kalra, S. P., and Kalra, P. S. (2004a). NPY and cohorts in regulating appetite, obesity and metabolic syndrome: beneficial effects of gene therapy. Neuropeptides 38, 201-211.
116. Kalra, S. P., and Kalra, P. S. (2004b). NPY: an endearing journey in search of a neurochemical on/off switch for appetite, sex and reproduction. Peptides 25, 465-471.
117. Kaur, G., and Kulkarni, S. K. (2001). Subchronic studies on modulation of feeding behavior and body weight by neurosteroids in female mice. Methods Find. Exp. Clin. Pharmacol. 23, 115-119.
118. Kavaliers, M., and Hirst, M. (1986). An octadecaneuropeptide (ODN) derived from diazepam binding inhibitor increases aggressive interactions in mice. Brain Res. 383, 343-349.
119. Kavaliers, M., and Kinsella, D. M. (1995). Male preference for the odors of estrous female mice is reduced by the neurosteroid pregnenolone sulfate. Brain Res. 682, 222-226.
120. Kikuyama, S., Hasunuma, I., Toyoda, F., Haraguchi, S., and Tsutsui, K. (2009). Hormonemediated reproductive behavior in the redbellied newt. Ann. N. Y. Acad. Sci. 1163, 79-86.
121. Kikuyama, S., Tanaka, S., and Moore, F. L. (2003). "Reproductive biology and phylogeny of urodela," in Endocrinology of Reproduction,ed. D. M. Sever (Enfield, NH: Science Publishers), 275-321.
122. Kimonides,V. G., Khatibi, N. H., Svendsen,C. N.,Sofroniew,M.V.,and Herbert, J. (1998). Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acidinduced neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 95, 1852-1857.
123. Kimonides, V. G., Spillantini, M. G., Sofroniew, M. V., fawcett, J. W., and Herbert, J. (1999). Dehydroepiandrosterone antagonizes the neurotoxic effects of corticosterone and translocation of stressactivated protein kinase 3 in hippocampal primary cultures. Neuroscience 89, 429-436.
124. Klaassen, C. D., and Boles, J. W. (1997). Sulfation and sulfotransferases 5: the importance of 3′-phosphoadenosine 5′-phosphosulfate (PAPS) in the regulation of sulfation. FASEB J. 11, 404-418.
125. Koenig, H. L., Schumacher, M., Ferzaz, B., Do, T. A. N., Ressouches, A., Guennoun, R., Jung-Testas, I., Robel, P., Akwa,Y., and Baulieu, E. E. (1995). Progesterone synthesis and myelin formation by Schwann cells. Science 268, 1500-1503.
126. Kohjitani, A., Fuda, H., Hanyu, O., and Strott, C. A. (2006). Cloning, characterization and tissue expression of rat SULT2B1a and SULT2B1b steroid/sterol sulfotransferase isoforms: divergence of the rat SULT2B1 gene structure from orthologous human and mouse genes. Gene 367, 66-73.
127. Kostowski, W., and Bienkowski, P. (1999). Discriminative stimulus effects of ethanol: neuropharmacological characterization. Alcohol 17, 63-80.
128. Koyama, T., Haraguchi, S., Vaudry, H., and Tsutsui, K. (2009). Diurnal changes in the synthesis of 7α-hydroxypregnenolone stimulating locomotor activity in newts. Ann. N. Y. Acad. Sci. 1163, 444-447.
129. Krnjevic, K., and Schwartz, S. (1966). Is gammaaminobutyric acid an inhibitory transmitter? Nature 211, 1372-1374.
130. Ladurelle, N., Eychenne, B., Denton, D., Blair-West, J., Schumacher, M., and Baulieu, E. E. (2000). Prolonged intracerebroventricular infusion of neurosteroids affects cognitive performances in the mouse. Brain Res. 858, 371-379.
131. Lancel, M., Faulhaber, J., Schiffelholz, T., Romeo, E., di Michele, F., Holsboer, F., and Rupprecht, R. (1997). Allopregnanolone affects sleep in a benzodiazepinelike fashion. J. Pharmacol. Exp. Ther. 282, 1213-1218.
132. Landgren, S., Backstrom, T., and Dubrovsky, B. (1987). The effect of progesterone and its metabolites on the interictal epileptiform discharge in the cat's cerebral cortex. Acta Physiol. Scand. 131, 33-42.
133. Lanthier, A., and Patwardhan, V. V. (1986). Sex steroids and 5-en-3β-hydroxysteroids in specific regions of the human brain and cranial nerves. J. Steroid Biochem. 25, 445-449.
134. Lapchak,P.A.,andAraujo,D. M. (2001). Preclinical development of neurosteroids as neuroprotective agents for the treatment of neurodegenerative diseases. Int. Rev. Neurobiol. 46, 379-397.
135. Lapchak, P. A., Chapman, D. F., Nunez, S. Y., and Zivin, J. A. (2000). Dehydroepiandrosterone sulfate is neuroprotective in a reversible spinal cord ischemia model. Stroke 31, 1953-1957.
136. Larcher, A., Delarue, C., Homo-Delarche, F., Kikuyama, S., Kupryszewski, G., and Vaudry, H. (1992). Pharmacological characterization of vasotocin stimulation of phosphoinositide turnover in frog adrenal gland. Endocrinology 130, 475-483.
137. Larcher, A., Delarue, C., Idres, S., Lefebvre, H., Feuilloley, M., Vandesande, F., Pelletier, G., and Vaudry, H. (1989). Identification of VT-like immunoreactivity in chromaffin cells of the frog adrenal gland: effect of VT on corticosteroid secretion. Endocrinology 125, 2691-2700.
138. Laurine, E., Lafitte, D., Grégoire, C., Sérée, E., Loret, E., Douillard, S., Michel, B., Briand, C., and Verdier, J. M. (2003). Specific binding of dehydroepiandrosterone to the N terminus of the microtubuleassociated protein MAP2. J. Biol. Chem. 278, 29979-29986.
139. Le Foll, F., Louiset, E., Castel, H., Vaudry, H., and Cazin, L. (1997a). Electrophysiological effects of various neuroactive steroids on the GABAA receptor in pituitary melanotrope cells. Eur. J. Pharmacol. 331, 303-311.
140. Le Foll, F., Castel, H., Louiset, E., Vaudry, H., and Cazin, L. (1997b). Multiple modulatory effects of the neuroactive steroid pregnanolone on GABAA receptor in frog pituitary melanotrophs. J. Physiol. 504, 387-400.
141. Leskiewicz, M., Budziszewska, B., Basta-Kaim, A., Zajac, A., Kacinski, M., and Lason, W. (2006). Effects of neurosteroids on neuronal survival: molecular basis and clinical perspectives. Acta Neurobiol. Exp. (Wars.) 66, 359-367.
142. Lesouhaitier, O., Feuilloley, M., Lihrmann, I., Ugo, I., Fasolo, A., Tonon, M. C., and Vaudry, H. (1996). Localization of diazepambinding inhibitorrelated peptides and peripheral type benzodiazepine receptors in the frog adrenal gland. Cell Tissue Res. 283, 403-412.
143. Lesouhaitier, O., Feuilloley, M., and Vaudry, H. (1998). Effect of the triakontatetraneuropeptide (TTN) on corticosteroid secretion by the frog adrenal gland. J. Mol. Endocrinol. 20, 45-53.
144. Lihrmann, I., Plaquevent, J. C., Tostivint, H., Raijmakers, R., Tonon, M. C., Conlon, J. M., and Vaudry, H. (1994). Frog diazepambinding inhibitor: peptide sequence, cDNA cloning, and expression in the brain. Proc. Natl. Acad. Sci. U.S.A. 91, 6899-6903.
145. Lockhart, E. M., Warner, D. S., Pearlstein, R. D., Penning, D. H., Mehrabani, S., and Boustany, R. M. (2002). Allopregnanolone attenuates N-methyl-D-aspartateinduced excitotoxicity and apoptosis in human NT2 cell line in culture. Neurosci. Lett. 328, 33-36.
146. MacKenzie, E. M., Odontiadis, J., Le Melledo, J. M., Prior, T. I., and Baker, G. B. (2007). The relevance of neuroactive steroids in schizophrenia, depression, and anxiety disorders. Cell.Mol.Neurobiol.27, 541-574.
147. Magnaghi, V., Cavarretta, I., Galbiati, M., Martini, L., and Melcangi, R. C. (2001). Neuroactive steroids and peripheral myelin proteins. Brain Res. Rev. 37, 360-371.
148. Majewska, M. D. (1992). Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog. Neurobiol. 38, 379-395
149. Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L., and Paul, S. M. (1986). Steroid hormone metabolites are barbituratelike modulators of the GABA receptor. Science 232, 1004-1007.
150. Majewska, M. D., and Schwartz, R. D. (1987). Pregnenolonesulfate: an endogenous antagonist of the gammaaminobutyric acid receptor complex in brain? Brain Res. 404, 355-360.
151. Mak, P., Broussard, C., Vacy, K., and Broadbear, J. H. (2011). Modulation of anxiety behavior in the elevated plus maze using peptidic oxytocin and vasopressin receptor ligands in the rat. J. Psychopharmacol. (in press).
152. Malagon, M., Vaudry, H., Vallarino, M., Gracia-Navarro, F., and Tonon, M. C. (1992a). Distribution and characterization of endozepinelike immunoreactivity in the central nervous system of the frog Rana ridibunda. Peptides 13, 99-107.
153. Malagon, M., Vallarino, M., Tonon, M. C., and Vaudry, H. (1992b). Localization and characterization of diazepambinding inhibitor (DBI)-like peptides in the brain and pituitary of the trout (Salmo gairdneri). Brain Res. 576, 208-214.
154. Malagon, M., Vaudry, H., Van Strien, F., Pelletier, G., Gracia-Navarro, F., and Tonon, M. C. (1993). Ontogeny of diazepambinding inhibitorrelated peptides (endozepines) in the rat brain. Neuroscience 57, 777-786.
155. Malik, A. S., Narayan, R. K., and Wendling, W. W. (2003). A novel dehydroepiandrosterone analog improves functional recovery in a rat traumatic brain injury model. J. Neurotrauma 20, 463-476.
156. Mameli, M., Carta, M., Partridge, L. D., and Valenzuela, C. F. (2005). Neurosteroidinduced plasticity of immature synapses via retrograde modulation of presynaptic NMDA receptors. J. Neurosci. 25,2285-2294.
157. Manji, H. K., Quiroz, J. A., Sporn, J., Payne, J. L., Denicoff, K., and Gray, M. (2003). Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficulttotreat depression. Biol. Psychiatry 53, 707-742.
158. Marumoto, N., Murakami, N., Katayama, T., Kuroda, H., and Murakami, T. (1996). Effects of daily injections of melatonin on locomotor activity rhythms in rats maintained under constant bright or dim light. Physiol. Behav. 60, 767-773.
159. Matsuda, K., Tanaka, S., Yamamoto, K., and Kikuyama, S. (1990). Annual changes of plasma prolactin levels in the newt, Cynops pyrrhogaster. Zool. Sci. 7, 1143.
160. Matsuda, K., Wada, K., Miura, T., Maruyama, K., Shimakura, S. I., Uchiyama, M., Leprince, J., Tonon, M. C., and Vaudry, H. (2007). Effect of the diazepambinding inhibitorderived peptide, octadecaneuropeptide, on food intake in goldfish. Neuroscience 150, 425-432.
161. Matsunaga, M., Ukena, K., Baulieu, E. E., and Tsutsui, K. (2004). 7α-Hydroxypregnenolone acts as a neuronal activator to stimulate locomotor activity of breeding newts by means of the dopaminergic system. Proc. Natl. Acad. Sci. U.S.A. 101, 17282-17287.
162. Maurice, T., Grégoire, C., and Espallergues, J. (2006). Neuro(active)steroids actions at the neuromodulatory sigma1 (σ1) receptor: biochemical and physiological evidences, consequences in neuroprotection. Pharmacol. Biochem. Behav. 84, 581-597.
163. Mayo,W.,Dellu,F.,Robel,P.,Cherkaoui, J., Le Moal, M., Baulieu, E. E., and Simon, H. (1993). Infusion of neurosteroids into the nucleus basalis magnocellularis affects cognitive processes in the rat. Brain Res. 607, 324-328.
164. McDonald, A. J., and Mascagni, F. (1996). Immunohistochemical localization of the β2 and β3 subunits of the GABAA receptor in the basolateral amygdala of the rat and monkey. Neuroscience 75, 407-419.
165. McEwen, B. S. (1994). Steroid hormone actions on the brain: when is the genome involved? Horm. Behav. 28, 396-405.
166. Melcangi, R. C., Azcoitia, I., Ballabio, M., Cavarretta, I., Gonzalez, L. C., Leonelli, E., Magnaghi, V., Veiga, S., and Garcia-Segura, L. M. (2003). Neuroactive steroids influence peripheral myelination: a promising opportunity for preventing or treating agedependent dysfunctions of peripheral nerves. Prog. Neurobiol. 71, 57-66.
167. Meldrum, B. (1982). Pharmacology of GABA. Clin. Neuropharmacol. 5, 293-316.
168. Mellon, S., and Vaudry, H. (2001). Biosynthesis of neurosteroids and regulation of their synthesis. Int. Rev. Neurobiol. 46, 33-78.
169. Mellon, S. H., and Griffin, L. D. (2002). Neurosteroids: biochemistry and clinical significance. Trends Endocrinol. Metab. 13, 35-43.
170. Mensah-Nyagan, A. G., Do Rego, J. L., Beaujean, D., Luu-The, V., Pelletier, G., and Vaudry, H. (1999). Neurosteroids: expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system. Pharmacol. Rev. 51, 63-81.
171. Mensah-Nyagan, A. G., Feuilloley, M., Do Rego, J. L., Marcual, A., Lange, C., Tonon, M. C., Pelletier, G., and Vaudry, H. (1996). Localization of 17β-hydroxysteroid dehydrogenase and characterization of testosterone in the brain of the male frog. Proc. Natl. Acad. Sci. U.S.A. 93, 1423-1428.
172. Mensah-Nyagan, A. G., Feuilloley, M., Dupont, E., Do Rego, J. L., Leboulenger, F., Pelletier, G., and Vaudry, H. (1994). Immunocytochemical localization and biological activity of 3β-hydroxysteroid dehydrogenase in the central nervous system of the frog. J. Neurosci. 14, 7306-7318.
173. Meyer-Lindenberg, A., Domes, G., Kirsch, P., and Heinrichs, M. (2011). Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat. Rev. Neurosci. 12, 524-538.
174. Migues, P. V., Johnston, A. N., and Rose, S. P. (2002). Dehydroepiandrosterone and its sulphate enhance memory retention in dayold chicks. Neuroscience 109, 243-251.
175. Mitchell, E. A., Gentet, L. J., Dempster, J., and Belelli, D. (2007). GABAA and glycine receptormediated transmission in rat lamina II neurones: relevance to the analgesic actions of neuroactive steroids. J. Physiol. 583, 1021-1040.
176. Mo, Q., Lu, S. F., Hu, S., and Simon, N. G. (2004). DHEA and DHEA sulfate differentially regulate neural androgen receptor and its transcriptional activity. Brain Res. Mol. Brain Res. 126, 165-172.
177. Mocchetti, I., Einstein, R., and Brosius, J. (1986). Putative diazepam binding inhibitor peptide: cDNA clones from rat. Proc. Natl. Acad. Sci. U.S.A. 83, 7221-7225.
178. Monnet, F. P., Mahe, V., Robel, P., and Baulieu, E. E. (1995). Neurosteroids,via σ receptors,modulate the [3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus. Proc. Natl. Acad. Sci. U.S.A. 92, 3774-3778.
179. Monnet, F. P., and Maurice, T. (2006). The sigma1 protein as a target for the nongenomic effects of neuro(active)steroids: molecular, physiological, and behavioral aspects. J. Pharmacol. Sci. 100, 93-118.
180. Moore, F. L., Boyd, S. K., and Kelley, D. B. (2005). Historical perspective: hormonal regulation of behaviors in amphibians. Horm. Behav. 48, 373-383.
181. Morrow, A. L. (2007). Recent developments in the significance and therapeutic relevance of neuroactive steroids -introduction to the special issue. Pharmacol. Ther. 116, 1-6.
182. Mosconi, G., Yamamoto, K., Kikuyama, S., Carnevali, O., Mancuso, A., and Vellano, C. (1994). Seasonal changes of plasma prolactin concentration in the reproduction of the crested newt (Triturus carnifex Laur). Gen. Comp. Endocrinol. 95, 342-349.
183. Murakami, K., Fellous, A., Baulieu, E. E., and Robel, P. (2000). Pregnenolone binds to microtubuleassociated protein 2 and stimulates microtubule assembly. Proc. Natl. Acad. Sci. U.S.A. 97, 3579-3584.
184. Murakami, N., Kawano, T., Nakahara, K., Nasu, T., and Shiota, K. (2001). Effect of melatonin on circadian rhythm, locomotor activity and body temperature in the intact house sparrow, Japanese quail and owl. Brain Res. 889, 220-224.
185. Nasman, B., Olsson, T., Backstrom, T., Eriksson, S., Grankvist, K., Vitanen, M., and Bucht, G. (1991). Serum dehydroepiandrosterone sulfate in Alzeimer's disease and in multiinfarct dementia. Biol. Psychiatry 30, 684-690.
186. Nguyen, A. D., Herzog, H., and Sainsbury, A. (2011). Neuropeptide Y and peptide YY. Important regulators of energy metabolism. Curr. Opin. Endocrinol. Diabetes Obes. 18,56-60.
187. Papadopoulos, V. (1993). Peripheraltype benzodiazepine/diazepam binding inhibitor receptor: biological role in steroidogenic cell function. Endocr. Rev. 14, 222-240.
188. Papadopoulos, V., Baraldi, M., Guilarte, T. R., Knudsen, T. B., Lacapère, J. J., Lindemann, P., Norenberg, M. D., Nutt, D., Weizman, A., Zhang, M. R., and Gavish, M. (2006). Translocator protein (18kDa): new nomenclature for the peripheraltype benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol. Sci. 27, 402-409.
189. Papadopoulos, V., Berkovich, A., and Krueger, K. E. (1991a). The role of diazepam binding inhibitor and its processing products at mitochondrial benzodiazepine receptors: regulation of steroid biosynthesis. Neuropharmacology 30, 1417-1423.
190. Papadopoulos, V., Berkovich, A., Krueger, K. E., Costa, E., and Guidotti, A. (1991b). Diazepam binding inhibitor and its processing products stimulate mitochondrial steroid biosynthesis via an interaction with mitochondrial benzodiazepine receptors. Endocrinology 129, 1481-1488.
191. Papadopoulos,V., Guarneri, P., Krueger, K. E., Guidotti, A., and Costa, E. (1992). Pregnenolone biosynthesis in C6-2B glioma cell mitochondria: regulation by a mitochondrial diazepam binding inhibitor receptor. Proc. Natl. Acad. Sci. U.S.A. 89, 5113-5117.
192. Papadopoulos,V., Mukhin, A. G., Costa, E., and Krueger, K. E. (1990). The peripheraltype benzodiazepine receptor is functionally linked to Leydig cell steroidogenesis. J. Biol. Chem. 265, 3772-3779.
193. Paredes, R. G., and Agmo, A. (1992). GABA and behavior: the role of receptor subtypes. Neurosci. Biobehav. Rev. 16, 145-170.
194. Park-Chung, M., Malayev, A., Purdy, R. H., Gibbs, T. T., and Farb, D. H. (1999). Sulfated and unsulfated steroids modulate gammaaminobutyric acid A receptor function through distinct sites. Brain Res. 830, 72-87.
195. Patchev, V. K., Hassan, A. H. S., Holsboer, F., and Almeida, O. F. X. (1996). The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoidlike effects on vasopressin gene transcription in the rat hypothalamus. Neuropsychopharmacology 15, 533-540.
196. Paul, S. M., and Purdy, S. H. (1992). Neuroactive steroids. FASEB J. 6, 2311-2322.
197. Pham, J., Porter, J., Svec, D., Eiswirth, C., and Svec, F. (2000). The effect of dehydroepiandrosterone on Zucker rats selected for fat food preference. Physiol. Behav. 70, 431-441.
198. Pinna, G., Agis-Balboa, R. C., Pibiri, F., Nelson, M., Guidotti, A., and Costa, E. (2008). Neurosteroid biosynthesis regulates sexually dimorphic fear and aggressive behavior in mice. Neurochem. Res. 33, 1990-2007.
199. Plassart-Schiess, E., and Baulieu, E. E. (2001). Neurosteroids: recent findings. Brain Res. Rev. 37, 133-140.
200. Polzonetti-Magni, A., Carnevali, O., Yamamoto, K., and Kikuyama, S. (1995). Growth hormone and prolactin in amphibian reproduction. Zool. Sci. 12, 683-694.
201. Ramos, E. J., Meguid, M. M., Campos, A. C., and Coelho, J. C. (2005). Neuropeptide Y, α-melanocytestimulating hormone, and monoamines in food intake regulation. Nutrition 21, 269-279.
202. Reddy, D. S. (2003). Pharmacology of endogenous neuroactive steroids. Crit. Rev. Neurobiol. 15, 197-234.
203. Reddy, D. S. (2010). Neurosteroids: endogenous role in the human brain and therapeutic potentials. Prog. Brain Res. 186, 113-137.
204. Reddy, D. S., and Kulkarni, S. K. (1998). The role of the GABA-A and mitochondrial diazepambinding inhibitor receptors on the effects of neurosteroids on food intake in mice. Psychopharmacology (Berl.) 137, 391-400.
205. Reddy, D. S., and Kulkarni, S. K. (1999). Sex and estrous cycledependent changes in neurosteroid and benzodiazepine effects on food consumption and plusmaze learning behaviors in rats. Pharmacol. Biochem. Behav. 62, 53-60.
206. Reghunandanan, V., Reghunandanan, R., and Mahajan, K. K. (1998). Arginine vasopressin as a neurotransmitter in brain. Indian J. Exp. Biol. 36, 635-643.
207. Remage-Healey, L., Maidment, N. T., and Schlinger, B. A. (2008). Forebrain steroid levels fluctuate rapidly during social interactions. Nat. Neurosci. 11, 1327-1334.
208. Richards, J. G., and Möhler, H. (1984). Benzodiazepine receptors. Neuropharmacology 23, 233-242.
209. Robel, P., and Baulieu, E. E. (1985). Neurosteroids, 3β-hydroxy-Δ5-derivatives in the rodent brain. Neurochem. Int. 7, 953-958.
210. Robel,P.,and Baulieu,E. E. (1994). Neurosteroids: biosynthesis and function. Trends Endocrinol. Metab. 5, 1-8.
211. Robel, P., Schumacher, M., and Baulieu, E. E. (1999). "Neurosteroids: from definition and biochemistry to physiopathologic function," in Contemporary Endocrinology, eds E. E. Baulieu, P. Robel, and M. Schumacher (Totowa: Humana Press), 1-26.
212. Robel,P.,Young,J.,Corpéchot,C.,Mayo, W., Perche, F., Haug, M., Simon, H., and Baulieu, E. E. (1995). Biosynthesis and assay of neurosteroids in rats and mice: functional correlates. J. Steroid Biochem. Mol. Biol. 53, 355-360.
213. Roberts, E. (1986). "Guides through the labyrinth of AD: dehydroepiandrosterone, potassium channels and the C4 component of complement," in Treatment Development Strategies for Alzheimer's Disease eds T. Crook, R. T. Bartus, S. Ferris, and S. Gershon (Madison, CT: Prowley), 173-219.
214. Rose, T. M., Schultz, E. R., and Todaro, G. J. (1992). Molecular cloning of the gene for the yeast homolog (ACB) of diazepam binding inhibitor/endozepine/acyl-CoA-binding protein. Proc. Natl. Acad. Sci. U.S.A. 89, 11287-11291.
215. Rupprecht, R. (1997). The neuropsychopharmacological potential of neuroactive steroids. J. Psychiatr. Res. 31, 297-314.
216. Rupprecht, R., di Michele, F., Hermann, B., Ströhle, A., Lancel, M., Romeo, E.,and Holsboer,F. (2001). Neuroactive steroids: molecular mechanisms of action and implications for neuropsychopharmacology. Brain Res. Rev. 37, 59-67.
217. Rupprecht, R., and Holsboer, F. (1999). Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci. 22, 410-416.
218. Rupprecht, R., and Holsboer, F. (2001). Neuroactive steroids in neuropsychopharmacology. Int. Rev. Neurobiol. 46, 461-477.
219. Sakaue, M., Saito, N., Taniguchi, H., Baba, S., and Tanaka, C. (1988). Immunohistochemical localization of γ-aminobutyric acid in the rat pituitary gland and related hypothalamic regions. Brain Res. 446, 343-353.
220. Sayeed, I., Guo, Q., Hoffman, S. W., and Stein, D. G. (2006). Allopregnanolone, a progesterone metabolite, is more effective than progesterone in reducing cortical infarct volume after transient middle cerebral artery occlusion. Ann. Emerg. Med. 47, 381-389.
221. Schiess, A. R., and Partridge, L. D. (2005). Pregnenolone sulfate acts through a G-proteincoupled sigma1-like receptor to enhance short term facilitation in adult hippocampal neurons. Eur. J. Pharmacol. 25, 22-29.
222. Schlinger, B. A., and Remage-Healey, L. (2011). Neurosteroidogenesis: insights from studies of songbirds. J. Neuroendocrinol. 24, 16-21.
223. Schumacher, M., Akwa, Y., Guennoun, R., Robert, F., Labombarda, F., Desarnaud, F., Robel, P., De Nicola, A. F., and Baulieu, E. E. (2000). Steroid synthesis and metabolism in the nervous system: trophic and protective effects. J. Neurocytol. 29, 307-326.
224. Schumacher, M., Weill-Engerer, S., Liere, P., Robert, F., Franklin, R. J., Garcia-Segura, L. M., Lambert, J. J., Mayo, W., Melcangi, R. C., Parducz, A., Suter, U., Carelli, C., Baulieu, E. E., and Akwa, Y. (2003). Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Prog. Neurobiol. 71, 3-29.
225. Shannon, E. E., Purdy, R. H., and Grant, K. A. (2005a). Discriminative stimulus effects of 5.6mg/kg pregnanolone in DBA/2J and C57BL/6J inbred mice. Alcohol 37, 35-45.
226. Shannon, E. E., Porcu, P., Purdy, R. H., and Grant, K. A. (2005b). Characterization of the discriminative stimulus effects of the neuroactive steroid pregnanolone in DBA/2J and C57BL/6J inbred mice. J. Pharmacol. Exp. Ther. 314, 675-685.
227. Shimada, M., Yoshinari, K., Tanabe, E., Shimakawa, E., Kobashi, M., Nagata, K., and Yamazoe, Y. (2001). Identification of ST2A1 as a rat brain neurosteroid sulfotransferase mRNA. Brain Res. 920, 222-225.
228. Shimizu, C., Fuda, H., Yanai, H., and Strott, C. A. (2003). Conservation of the hydroxysteroid sulfotransferase SULT2B1 gene structure in the mouse: preand postnatal expression, kinetic analysis of isoforms, and comparison with prototypical SULT2A1. Endocrinology 144, 1186-1193.
229. Slobodyansky, E., Guidotti, A., Wambebe, C., Berkovich, A., and Costa, E. (1989). Isolation and characterization of a triakontatetraneuropeptide (TTN) a posttranslational product of diazepam binding inhibitor: specific action at the Ro5-4864 recognition sites. J. Neurochem. 53, 1276-1284.
230. Slobodyansky, E., Kurriger, G., and Kultas-Llinsky, K. (1992). Diazepam binding inhibitor processing in the rhesus monkey brain: an immunocytochemical study. J. Chem. Neuroanat. 5, 169-180.
231. Steffensen, S. C., Jones, M. D., Hales, K., and Allison, D. W. (2006). Dehydroepiandrosterone sulfate and estrone sulfate reduce GABA-recurrent inhibition in the hippocampus via muscarinic acetylcholine receptors. Hippocampus 16, 1080-1090.
232. Stein, D. G. (2001). Brain damage, sex hormones and recovery: a new role for progesterone and estrogen? Trends Neurosci. 24, 386-391.
233. Strott, C. A. (2002). Sulfonation and molecular action. Endocr. Rev. 23, 703-732.
234. Strous, R. D., Maayan, R., Lapidus, R., Stryjer, R., Lustig, M., Kotler, M., and Weizman, A. (2003). Value of dehydroepiandrosterone (DHEA) augmentation in the management of negative symptoms in schizophrenia. Arch. Gen. Psychiatry 60, 133-141.
235. Strous, R. D., Maayan, R., and Weizman, A. (2006). The relevance of neurosteroids to clinical psychiatry: from the laboratory to the bedside. Eur. Neuropsychopharmacol. 16, 155-169.
236. Sunderland, T., Merril, C. R., Harrington, M. G., Lawlor, B. A., Molchan, S. E., Martinez, R., and Murphy, D. L. (1989). Reduced plasma dehydroepiandrosterone concentrations in Alzheimer's disease. Lancet 2, 570.
237. Svec, F., and Porter, J. (1996). Effect of DHEA on macronutrient selection by Zucker rats. Physiol. Behav. 59, 721-727.
238. Svec, F., and Porter, J. (1998a). Dehydroepiandrosterone: a nutritional supplement with actions in the central nervous system. Nutr. Neurosci. 1, 9-19.
239. Svec, F., and Porter, J. (1998b). The actions of exogenous dehydroepiandrosterone in experimental animals and humans. Proc. Soc. Exp. Biol. Med. 218, 174-191.
240. Svec, F., Richards, R. J., and Porter, J. R. (1998). Investigating the debate: does DHEA alter food intake? Nutr. Neurosci. 1, 93-101.
241. Takase, M., Ukena, K., Yamazaki, T., Kominami, S., and Tsutsui, K. (1999). Pregnenolone, pregnenolone sulfate, and cytochrome P450 sidechain cleavage enzyme in the amphibian brain and their seasonal changes. Endocrinology 140, 1936-1944.
242. Tappaz, M. L., Wassef, M., Oertel, W. H., Paut, L., and Pujol, J. F. (1983). Lightand electronmicroscopic immunocytochemistry of glutamic acid decarboxylase (GAD) in the basal hypothalamus: morphological evidence for neuroendocrine γ-aminobutyrate (GABA). Neuroscience 9, 271-287.
243. Tasan, R. O., Lin, S., Hetzenauer, A., Singewald, N., Herzog, H., and Sperk, G. (2009). Increased noveltyinduced motor activity and reduced depressionlike behavior in neuropeptide Y (NPY)-Y4 receptor knockout mice. Neuroscience 158, 1717-1730.
244. Tasker, J. G., Di, S., and Malcher-Lopes, R. (2006). Minireview: rapid glucocorticoid signaling via membraneassociated receptors. Endocrinology 147, 5549-5556.
245. Thompson, R. R., Dickinson, P. S., Rose, J. D., Dakin, K. A., Civiello, G. M., Segerdahl, A., and Bartlett, R. (2008). Pheromones enhance somatosensory processing in newt brains through a vasotocindependent mechanism. Proc. Biol. Sci. 275, 1685-1693.
246. Thorsell, A. (2010). Brain neuropeptide Y and corticotropinreleasing hormone in mediating stress and anxiety. Exp. Biol. Med. 235, 1163-1167.
247. Todaro, G. J., Rose, T. M., and Shoyab, M. (1991). Human DBI (endozepine): relationship to a homologous membrane associated protein (MA-DBI). Neuropharmacology 30, 1373-1380.
248. Tong, Y., Toranzo, D., and Pelletier, G. (1991). Localization of diazepambinding inhibitor (DBI) mRNA in the rat brain by high resolution in situ hybridization. Neuropeptides 20, 33-40.
249. Tonon, M. C., Désy, L., Nicolas, P., Vaudry, H., and Pelletier, G. (1990). Immunocytochemical localization of the endogenous benzodiazepine ligand octadecaneuropeptide (ODN) in the rat brain. Neuropeptides 15, 17-24.
250. Tonon, M. C., Leprince, J., Gandolfo, P., Compère, V., Pelletier, G., Malagon, M. M., and Vaudry, H. (2006). "Endozepines," in Handbook of Biologically Active Peptides,ed. A. J. Kastin (New York: Elsevier), 813-819.
251. Torres, J. M., and Ortega, E. (2003). DHEA, PREG and their sulfate derivatives on plasma and brain after CRH and ACTH administration. Neurochem. Res. 28, 1187-1191.
252. Toyoda, F., Hasunuma, I., Yamamoto, K., Yamashita, M., and Kikuyama, S. (2005). Prolactin acts centrally to enhance newt courtship behavior. Gen. Comp. Endocrinol. 141, 172-177.
253. Toyoda, F., Ito, M., Tanaka, S., and Kikuyama, S. (1993). Hormonal induction of male courtship behavior in the Japanese newt, Cynops pyrrhogaster. Horm. Behav. 27, 511-522.
254. Tsutsui, K., Haraguchi, S., Matsunaga, M., Koyama, T., Do Rego, J. L., and Vaudry, H. (2010). Identification of 7α-hydroxypregnenolone, a novel bioactive amphibian neurosteroid stimulating locomotor activity, and its physiological roles in the regulation of locomotion. Gen. Comp. Endocrinol. 168, 275-279.
255. Tsutsui, K., Inoue, K., Miyabara, H., Suzuki, S., Ogura, Y., and Tobari, Y. And Haraguchi, S. (2009). Discovery of a novel avian neurosteroid, 7α-hydroxypregnenolone,and its role in the regulation of the diurnal rhythm of locomotor activity in Japanese quail. Gen. Comp. Endocrinol. 163, 117-122.
256. Tsutsui, K., Inoue, K., Miyabara, H., Suzuki, S., Ogura, Y.,and Haraguchi, S. (2008). 7α-Hydroxypregnenolone mediates melatonin action underlying diurnal locomotor rhythms. J. Neurosci. 28, 2158-2167.
257. Tsutsui, K., Matsunaga, M., Miyabara, H., and Ukena, K. (2006). Neurosteroid biosynthesis in the quail brain: a review. J. Exp. Zoolog. Part A Comp. Exp. Biol. 305, 733-742.
258. Tsutsui, K., Matsunaga, M., and Ukena, K. (2003). Review: biosynthesis and biological actions of neurosteroids in the avian brain. Avian Poultry Biol. Rev. 14, 63-78.
259. Tsutsui, K., Ukena, K., Takase, M., Kohchi, C., and Lea, R. W. (1999). Neurosteroid biosynthesis in vertebrate brains. Comp. Biochem. Physiol. C Pharmacol. Toxicol. Endocrinol. 124, 121-129.
260. Tsutsui, K., and Yamazaki, T. (1995). Avian neurosteroids I. Pregnenolone biosynthesis in the quail brain. Brain Res. 678, 1-9.
261. Ueno, H., Yamaguchi, H., Mizuta, M., and Nakazato, M. (2008). The role of PYY in feeding regulation. Regul. Pept. 145, 12-16.
262. Uzunova, V., Ceci, M., Kohler, C., Uzunov, D. P., and Wrynn, A. S. (2003). Regionspecific dysregulation of allopregnanolone brain content in the olfactory bulbectomized rat model of depression. Brain Res. 976, 1-8.
263. Valera, S., Ballivet, M., and Bertrand, D. (1992). Progesterone modulates a neuronal nicotinic acetylcholine receptor. Proc. Natl. Acad. Sci. U.S.A. 89, 9949-9953.
264. Vallée, M., Mayo, W., Darnaudery, M., Corpéchot, C., Young, J., Koehl, M., Le Moal, M., Baulieu, E. E., Robel, P., and Simon, H. (1997). Neurosteroids: deficient cognitive performance in aged rats depends on low pregnenolone sulfate levels in the hippocampus. Proc. Natl. Acad. Sci. U.S.A. 94, 14865-14870.
265. Vallée, M., Mayo, W., and Le Moal, M. (2001). Role of pregnenolone, dehydroepiandrosterone and their sulfate esters on learning and memory in cognitive ageing. Brain Res. Rev. 37, 301-312.
266. van Broekhoven, F., and Verkes, R. J. (2003). Neurosteroids in depression: areview.Psychopharmacology (Berl.) 165, 97-110.
267. Vaudry, H., Do Rego, J. L., Burel, D., Luu-The, V., Pelletier, G., and Tsutsui, K. (2011). Neurosteroid biosynthesis in the brain of amphibians. Front. Neuroendocr. Sci. 2:79. doi:10.3389/fendo.2011.00079
268. Viglietti-Panzica, C., Aste, N., Balthazart, J., and Panzica, G. C. (1994). Vasotocinergic innervation of sexually dimorphic medial preoptic nucleus of the male Japanese quail: influence of testosterone. Brain Res. 657, 171-184.
269. von Horsten, S., Exton, N. G., Exton, M. S., Helfritz, F., Nave, H., Ballof, J., Stalp, M., and Pabst, R. (1998). Brain NPY Y1 receptors rapidly mediate the behavioral response to novelty and a compartmentspecific modulation of granulocyte function in blood and spleen. Brain Res. 806, 282-286.
270. Warren, W. S., and Cassone, V. M. (1995). The pineal gland: photoreception and coupling of behavioral, metabolic, and cardiovascular circadian outputs. J. Biol. Rhythms 10, 64-79.
271. Weaver, Jr. C. E., Marek, P., Park-Chung, M., Tam, S. W., and Farb, D. H. (1997). Neuroprotective activity of a new class of steroidal inhibitors of the N-methyl-D-aspartate receptor. Proc. Natl. Acad. Sci. U.S.A. 94, 10450-10454.
272. Wehrenberg,W. B.,Corder, R., and Gaillard, R. C. (1989). A physiological role for neuropeptide Y in regulating the estrogen/progesterone induced luteinizing hormone surge in ovariectomized rats. Neuroendocrinology 49, 680-682.
273. Weill-Engerer, S., David, J. P., Sazdovitch, V., Liere, P., Eychenne, B., Pianos, A., Schumacher, M., Delacourte, A., Baulieu, E. E., and Akwa, Y. (2002). Neurosteroid quantification in human brain regions: comparison between Alzheimer's and nondemented patients. J. Clin. Endocrinol. Metab. 87, 5138-5143.
274. Wojtal,K.,Trojnar,M. K.,and Czuczwar, S. J. (2006). Endogenous neuroprotective factors: neurosteroids. Pharmacol. Rep. 58, 335-340.
275. Woolley, S. C., Sakata, J. T., and Crews, D. (2004). Evolutionary insights into the regulation of courtship behavior in male amphibians and reptiles. Physiol. Behav. 83, 347-360.
276. Wu, F. S., Gibbs, T. T., and Farb, D. H. (1991). Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor. Mol. Pharmacol. 40, 333-336.
277. Xilouri, M., and Papazafiri, P. (2006). Antiapoptotic effects of allopregnanolone on P19 neurons. Eur. J. Neurosci. 23, 43-54.
278. Yanagibashi, K., Ohno, Y., Nakamichi, N., Matsui, T., Hayashida, K., Takamura, M., Yamada, K., Tou, S., and Kawamura, M. (1989). Peripheraltype benzodiazepine receptors are involved in the regulation of cholesterol side chain cleavage in adrenocortical mitochondria. J. Biochem. 106, 1026-1029.
279. Yanase, H., Shimizu, H., Yamada, K., and Iwanaga, T. (2002). Cellular localization of the diazepam binding inhibitor in glial cells with special reference to its coexistence with braintype fatty acid binding protein. Arch.Histol.Cytol.65, 27-36.
280. Young, L. T. (2002). Neuroprotective effects of antidepressant and mood stabilizing drugs. J. Psychiatry Neurosci. 27, 8-9.
281. Zheng, P. (2009). Neuroactive steroid regulation of neurotransmitter release in the CNS: action, mechanism and possible significance. Prog. Neurobiol. 89, 134-152.
282. Zwain, I. H., Arroyo, A., Amato, P., and Yen, S. S. (2002). A role for hypothalamic astrocytes in dehydroepiandrosterone and estradiol regulation of gonadotropinreleasing hormone (GnRH) release by GnRH neurons. Neuroendocrinology 75, 375-383.